Edit

Biomedicine

Melanoma Monitor

  • December 20, 2011

It can be difficult for dermatologists to correctly identify early-stage skin cancer. To assist them, this device uses a multispectral camera to peer below the skin surface. Using a database of lesions for comparison, the system can recommend that a mole be biopsied. Its accuracy rate is higher than that of a standard examination alone.

Product: MelaFind
Cost: $7,500:
Availability: Now
Source: www.melasciences.com
Companies: Mela Sciences

Uh oh–you've read all five of your free articles for this month.

Insider Online Only

$19.95/yr US PRICE

Biomedicine

New technologies and biological insights are providing unprecedented ways of improving our health.

You've read of free articles this month.